A mouse model for glucocorticoid-induced osteonecrosis: Effect of a steroid holiday

Journal of Orthopaedic Research

Volumn 27, Issue 2, 2009, Pages 169-175

  Yang, Lei ^a,b   Boyd, Kelli ^a   Kaste, Sue C ^a,b   Kamdem, Landry ^a   Rahija, Richard J ^a   Relling, Mary V ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Glucocorticoid; Mouse model; Osteonecrosis

Indexed keywords

ASPARAGINASE; DEXAMETHASONE; GLUCOCORTICOID; STEROID; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BONE NECROSIS; CLINICAL FEATURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HISTOPATHOLOGY; INCIDENCE; MALE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; TRABECULAR BONE; A J MOUSE; AKR MOUSE; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DBA MOUSE; DISEASE MODEL; DOSE RESPONSE; GENETICS; PATHOLOGY; PHENOTYPE; SPECIES DIFFERENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; ASPARAGINASE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; MALE; MICE; MICE, INBRED A; MICE, INBRED AKR; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; OSTEONECROSIS; PHENOTYPE; SPECIES SPECIFICITY;

EID: 59449099878     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20733     Document Type: Article

References (39)

1. van Vugt RM, Sijbrandij ES, Bijlsma JW. 1996. Magnetic resonance imaging of the femoral head to detect avascular necrosis in active rheumatoid arthritis treated with methylprednisolone pulse therapy. Scand J Rheumatol 25:74-76.
2. Zizic TM. 1991. Osteonecrosis. Curr Opin Rheumatol 3:481-489.
3. Tsurko VV, Ivanova MM, Tokmachev I. 1995. Corticosteroid therapy and aseptic bone necrosis in patients with rheumatoid arthritis. Ter Arkh 67:71-74.
4. Burger B, Beier R, Zimmermann M, et al. 2005. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) - experiences from trial ALL-BFM 95. Pediatr Blood Cancer 44:220-225.
5. Mattano LA Jr, Sather HN, Trigg ME, et al. 2000. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 18:3262-3272.
6. Arico M, Boccalatte MF, Silvestri D, et al. 2003. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88:747-753.
7. Smith RW, Margulis RR, Brennan MJ, et al. 1950. The influence of ACTH and cortisone on certain factors of blood coagulation. Science 112:295-297.
8. Yamamoto T, Hirano K, Tsutsui H, et al. 1995. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop Relat Res 316:235-243.
9. Glueck CJ, Freiberg RA, Fontaine RN, et al. 2001. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 386:19-33.
10. Miyanishi K, Yamamoto T, Irisa T, et al. 2001. A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits. Rheumatology (Oxford) 40:196-201.
11. Yamamoto T, Irisa T, Sugioka Y, et al. 1997. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 40:2055-2064.
12. Mattano L, Sather HN, La MK, et al. 2003. Modified dexamethasone (DXM) reduces the incidence of treatment-related osteonecrosis (ON) in children and adolescents with higher risk acute lymphoblastic leukemia (HR ALL): a report of CCG-1961 (Abstract 777). Blood 102:221a.
13. Kroot EJ, Huisman AM, Van ZJ, et al. 2006. Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study. Ann N Y Acad Sci 1069:300-306.
14. Frediani B, Falsetti P, Bisogno S, et al. 2004. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J Rheumatol 31:1083-1087.
15. Hui L, Wiernik PH. 1996. Avascular necrosis of bone after adult acute lymphocytic leukemia treatment with methotrexate, vincristine, L-asparaginase, and dexamethasone (MOAD). Am J Hematol 52:184-188.
16. Hanada T, Horigome Y, Inudoh M, et al. 1989. Osteonecrosis of vertebrae in a child with acute lymphocytic leukaemia during L-asparaginase therapy. Eur J Pediatr 149:162-163.
17. Yang L, Panetta JC, Cai X, et al. 2008. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol 26:1932-1939.
18. Priest JR, Ramsay NK, Bennett AJ, et al. 1982. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 100:990-995.
19. Parsons SK, Skapek SX, Neufeld EJ, et al. 1997. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 89:1886-1895.
20. Steinherz PG. 1994. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer 74:3234-3239.
21. Relling MV, Yang W, Das S, et al. 2004. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 22:3930-3936.
22. Cui Q, Wang GJ, Su CC, et al. 1997. The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis. Clin Orthop Relat Res 344:8-19.
23. Wang GJ, Cui Q, Balian G. 2000. The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 370:295-310.
24. Conzemius MG, Brown TD, Zhang Y, et al. 2002. A new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure. J Orthop Res 20:303-309.
25. breu-Silva AL, Calabrese KS, Cupolilo SM, et al. 2004. Histopathological studies of visceralized Leishmania (Leishmania) amazonensis in mice experimentally infected. Vet Parasitol 121:179-187.
26. Yamasaki K, Itakura C. 1988. Aseptic necrosis of bone in ICR mice. Lab Anim 22:51-53.
27. Walzer PD, Foy J, Steele P, et al. 1992. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 36:1935-1942.
28. Walzer PD, Powell RD Jr, Yoneda K. 1979. Experimental Pneumocystis carinii pneumonia in different strains of cortisonized mice. Infect Immun 24:939-947.
29. Yang S, Healey MC. 1993. The immunosuppressive effects of dexamethasone administered in drinking water to C57BL/6N mice infected with cryptosporidium parvum. J Parasitol 79:626-630.
30. Ling S, Jamali F. 2003. Effect of cannulation surgery and restraint stress on the plasma corticosterone concentration in the rat: application of an improved corticosterone HPLC assay. J Pharm Pharm Sci 6:246-251.
31. Mehvar R, Dann RO, Hoganson DA. 2000. Simultaneous analysis of methylprednisolone, methylprednisolone succinate, and endogenous corticosterone in rat plasma. J Pharm Biomed Anal 22:1015-1022.
32. Reiff A, Zastrow M, Sun BC, et al. 2001. Treatment of collagen induced arthritis in DBA/1 mice with L-asparaginase. Clin Exp Rheumatol 19:639-646.
33. Silverman LB, Gelber RD, Dalton VK, et al. 2001. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 97:1211-1218.
34. Kabata T, Kubo T, Matsumoto T, et al. 2005. Onset of steroid-induced osteonecrosis in rabbits and its relationship to hyperlipaemia and increased free fatty acids. Rheumatology (Oxford) 44:1233-1237.
35. Sissons HA, Nuovo MA, Steiner GC. 1992. Pathology of osteonecrosis of the femoral head. A. review of experience at the Hospital for Joint Diseases, New York. Skeletal Radiol 21:229-238.
36. Rico H, Gomez-Castresana F, Cabranes JA, et al. 1985. Increased blood cortisol in alcoholic patients with aseptic necrosis of the femoral head. Calcif Tissue Int 37:585-587.
37. Richter O, Ern B, Reinhardt D, et al. 1983. Pharmacokinetics of dexamethasone in children. Pediatr Pharmacol (New York) 3:329-337.
38. Halton JM, Nazir DJ, McQueen MJ, et al. 1998. Blood lipid profiles in children with acute lymphoblastic leukemia. Cancer 83:379-384.
39. Wilcken DE. 1997. MTHFR 677C → T mutation, folate intake, neural-tube defect, and risk of cardiovascular disease. Lancet 350:603-604.